Schonfeld Strategic Advisors’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Schonfeld Strategic Advisors’s Portfolio ISEE Stock Details ISEE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-2,500	Closed	-$250	–	2510
2023 Q2	$250	Buy	+2,500	New	+$88.2K	﹤0.01%	2078

Schonfeld Strategic Advisors's ISEE Position: Q3 2023 in Review

Schonfeld Strategic Advisors sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 28,645 shares — an estimated $1.13M sold.

Schonfeld Strategic Advisors first reported a position in ISEE in Q1 2016 and held it in 13 quarters. The position peaked at $8.3M in Q1 2023. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.

Schonfeld Strategic Advisors reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Schonfeld Strategic Advisors sold 28,645 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $1.13M.
Schonfeld Strategic Advisors first reported a position in IVERIC bio, Inc. Common Stock in Q1 2016 and held it in 13 quarters.
Schonfeld Strategic Advisors's IVERIC bio, Inc. Common Stock position peaked at $8.3M in Q1 2023.
0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.

Based on Schonfeld Strategic Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.